May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
A Novel CACNA1F Gene Mutation in the Original Family With Åland Island Eye Disease
Author Affiliations & Notes
  • R. Jalkanen
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Biomedicum Helsinki, Helsinki, Finland
    Department of Molecular Genetics and Population Genetics Unit, The Folkhälsan Institute of Genetics, Helsinki, Finland
  • N.T. Bech–Hansen
    Departments of Medical Genetics and Surgery, University of Calgary, Calgary, AB, Canada
  • R. Tobias
    Departments of Medical Genetics and Surgery, University of Calgary, Calgary, AB, Canada
  • A. de la Chapelle
    Comprehensive Cancer Center, Ohio State University, Columbus, OH
  • H. Forsius
    Department of Molecular Genetics and Population Genetics Unit, The Folkhälsan Institute of Genetics, Helsinki, Finland
  • T. Alitalo
    Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Biomedicum Helsinki, Helsinki, Finland
    Department of Medical Genetics, University of Helsinki, Helsinki, Finland
  • Footnotes
    Commercial Relationships  R. Jalkanen, None; N.T. Bech–Hansen, None; R. Tobias, None; A. de la Chapelle, None; H. Forsius, None; T. Alitalo, None.
  • Footnotes
    Support  the Finnish Eye and Tissue Bank Foundation, the Foundation Fighting Blindness – Canada, Canadian Institutes of Health Research
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4625. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. Jalkanen, N.T. Bech–Hansen, R. Tobias, A. de la Chapelle, H. Forsius, T. Alitalo; A Novel CACNA1F Gene Mutation in the Original Family With Åland Island Eye Disease . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4625.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Åland Island eye disease (AIED), also known as Forsius–Eriksson syndrome, is an X–chromosomal recessive retinal disease characterized by a combination of fundal hypopigmentation, decreased visual acuity due to foveal hypoplasia, nystagmus, astigmatism, progressive myopia and defective dark adaptation. AIED has been localized to the pericentromeric region of the X–chromosome, but the causative gene is still unknown. The purpose of this study was to identify the mutated gene underlying the disease phenotype in the original AIED family.

Methods: : All exons and flanking intronic regions of the CACNA1F gene were studied by direct PCR–based DNA sequencing. CACNA1F mRNA from cultured lymphoblasts was analyzed by RT–PCR and cDNA sequencing.

Results: : A novel deletion in the CACNA1F gene was identified, covering a single exon and portions of the flanking introns. Expression studies indicated that the particular exon was excluded from the mRNA. This CACNA1F mutation co–segregated completely with the disease phenotype in the AIED family and was not observed in 121 control chromosomes.

Conclusions: : Mutations in CACNA1F are known to cause the incomplete form of X–linked congenital stationary night blindness (CSNB2). It has long been discussed, whether AIED and CSNB2 are a single entity or allelic diseases. CACNA1F mutations have been identified in patients with an AIED–like phenotype, but previous studies failed to reveal any CACNA1F mutation in patients from the original AIED family. Our results now show that AIED is caused by a novel deletion mutation within CACNA1F.

Keywords: gene screening • mutations • retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×